Vertex Pharmaceuticals (VRTX) insider trading

By person

24 insiders · 0 transactions

31.8×

Reshma Kewalramani holds 31.8 times base salary in stock. $51.01M of shares against $1.60M in salary for 2025.

Salary from the company's own proxy. The shares are what Reshma Kewalramani last reported holding, valued at $519.00, the price Common Stock was last bought or sold at on the open market here, on 2 Jul 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Reshma Kewalramani

CEO & President

—

98,278

0.0388%

$51.01M

+8.0%

Amit Sachdev

EVP Chief Patient & Ext Af Off

—

66,512

0.0262%

$34.52M

+31.0%

Stuart A Arbuckle

EVP, COO

—

63,368

0.0250%

$32.89M

+27.4%

Ourania Tatsis

EVP, Chief Reg. & Quality Off.

—

53,572

0.0211%

$27.80M

+8.9%

Charles F Wagner Jr

EVP, Co & Fo

—

47,042

0.0186%

$24.41M

−0.3%

Bruce I Sachs

Director

—

39,000

0.0154%

$20.24M

−2.5%

Jeffrey M Leiden

Executive Chairman

—

34,797

0.0137%

$18.06M

+248.2%

David Altshuler

EVP, Chief Scientific Officer

—

34,477

0.0136%

$17.89M

+33.2%

Joy Liu

EVP and Chief Legal Officer

—

19,131

0.0075%

$9.93M

−19.5%

Edward Morrow Atkinson III

EVP, Chief Technical Ops. Off.

—

18,432

0.0073%

$9.57M

+15.4%

Carmen Bozic

EVP and CMO

—

15,337

0.0061%

$7.96M

−34.1%

Jonathan Biller

EVP and Chief Legal Officer

—

13,659

0.0054%

$7.09M

−18.0%

Kristen Ambrose

SVP & Chief Accounting Officer

—

11,624

0.0046%

$6.03M

+55.0%

Duncan McKechnie

EVP, Chief Commercial Officer

—

11,001

0.0043%

$5.71M

−32.1%

Grunsven Jasper van

EVP, CP and NPPO

—

8,682

0.0034%

$4.51M

—

Alan M Garber

Director

—

7,344

0.0029%

$3.81M

+13.4%

Mark E. Bunnage

EVP, Chief Scientific Officer

—

7,284

0.0029%

$3.78M

−54.7%

Lloyd Carney

Director

—

6,315

0.0025%

$3.28M

−0.1%

Sangeeta N. Bhatia

Director

—

4,924

0.0019%

$2.56M

+11.0%

Diana McKenzie

Director

—

2,378

0.0009%

$1.23M

−2.4%

Nancy Thornberry

Director

—

2,109

0.0008%

$1.09M

+28.8%

Suketu Upadhyay

Director

—

1,558

0.0006%

$808.60K

−39.1%

Jennifer Schneider

Director

—

1,394

0.0005%

$723.49K

+51.2%

Daniel J. Brennan

Director

—

795

0.0003%

$412.61K

—

Vertex Pharmaceuticals

What the insiders did No buying or selling

By person